semaglutide mouse Scientific Poster: Resmetirom and in MASH Model Study Distinct metabolic effects of semaglutide

In company-funded studies, participants taking Wegovy had average weight loss of 15%, about 34 pounds (15.3 kilograms)

Semaglutide and tirzepatide are intended as a maintenance medication used once a week

Second, the studies suggest that semaglutide might work through a different mechanism than existing asthma drugs, offering a new way to manage the disease

This transition is essential because these conditions share overlapping symptoms yet exhibit distinct endocrine and reward-related profiles that may influence treatment response and guide clinical decision-making

The agency says some patients and providers are turning to these alternatives when FDA-approved drugs are unavailable or costly

Semaglutide is not intended for short-term use